These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2230352)

  • 1. Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease.
    Allende MT; Vizoso F; Roiz MC; Fueyo A; Ruibal A
    Int J Biol Markers; 1990; 5(1):48-9. PubMed ID: 2230352
    [No Abstract]   [Full Text] [Related]  

  • 2. [The correlation between the serum concentrations of BCM (breast cancer mucin), CA549 and estradiol in women with breast macrocysts].
    Vizoso F; Allende MT; Fueyo A; Ruibal A
    Med Clin (Barc); 1991 Feb; 96(5):198. PubMed ID: 2033998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast].
    Vizoso F; Roiz MC; Allende MT; Ruibal A
    Med Clin (Barc); 1990 Mar; 94(8):319. PubMed ID: 2342398
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
    Yenisey C; Güner G
    Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of breast cancer mucin (BCM) and CA 15-3 in human breast cancer.
    Garcia MB; Blankenstein MA; van der Wall E; Nortier JW; Schornagel JH; Thijssen JH
    Breast Cancer Res Treat; 1990 Dec; 17(2):69-76. PubMed ID: 2096994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations of serum concentrations of CA 15.3 and estradiol in women with breast macrocystic disease].
    Vizoso F; Allende MT; Fueyo A; Vivanco J
    Med Clin (Barc); 1990 May; 94(20):798. PubMed ID: 2392013
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.
    Vizoso F; Allende MT; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum level of cryptic tumor antigens in breast cancer patients as determined by two monoclonal antibodies (M85/F36) and its comparison with CA 15-3.
    Chu TM; Constantine R; Nemoto T
    J Clin Lab Anal; 1989; 3(5):267-72. PubMed ID: 2681619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Riera L; López Otin C; Ruibal A
    Int J Biol Markers; 1991; 6(1):31-2. PubMed ID: 1906915
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between blood concentrations of CA 15.3 and estradiol in women with macrocystic disease of breast. Study in function of the type of cyst].
    Vizoso F; Allende MT; Díez MC; Ruibal A
    Rev Clin Esp; 1991 Nov; 189(8):390-1. PubMed ID: 1784805
    [No Abstract]   [Full Text] [Related]  

  • 12. CA 15.3 behaviour in cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Vigal G; García-Morán M; Ruibal A
    Int J Biol Markers; 1989; 4(3):181-2. PubMed ID: 2614087
    [No Abstract]   [Full Text] [Related]  

  • 13. High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic disease.
    Vizoso F; Allende MT; Fernàndez R; Suarez B; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(3):197-8. PubMed ID: 1791315
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer mucin antigen (BCM) determination by IMX: a preliminary study of epidemiological distribution of the serum levels in gynecological diseases.
    Torre GC; Barbetti V; Lanfranco E; Robutti M; Foglia M; Corongiu F; Vigliercio GP
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):59-62. PubMed ID: 2092151
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
    Daly L; Ferguson J; Cram GP; Hars V; George SL; McCarty KS; Bast RC
    J Clin Oncol; 1992 Jul; 10(7):1057-65. PubMed ID: 1607912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
    Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
    Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCA and CA 15.3 serum levels in non-malignant diseases. Some preliminary results.
    Soriano A; Allende MT; Vizoso F; Fernández García J; Vivanco J; Ruibal A
    Int J Biol Markers; 1990; 5(1):46-7. PubMed ID: 2230351
    [No Abstract]   [Full Text] [Related]  

  • 19. [The correlation between the serum concentrations of CA 549 and CA 15.3 in patients with cystic breast disease].
    Allende MT; Vizoso F; Fueyo A; Ruibal A
    Rev Clin Esp; 1990; 187(3):152-3. PubMed ID: 2284494
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenal steroids and tumor antigens in plasma and cyst fluid of women with gross cystic breast disease.
    Inaudi P; De Leo V; Baldini S; D'Antona N
    Ann N Y Acad Sci; 1990; 586():117-20. PubMed ID: 2356994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.